2
Total investments
0
Early stage
1
Mid stage
0
Late stage
17y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Interim Board Member and Audit Committee Member
Dec 2009
Out-of-pocket healthcare expenses are on the rise. Patients are having difficulty paying their share and providers are finding it difficult to collect from those patients. It’s a lose-lose situation.
Enter CarePayment. Our award-winning, always 0.00% APR patient financial engagement helps patients afford the care they need and protect their financial health while helping providers stay financially healthy by reducing bad debt and improving cash flow.
*#1 Patient Financing Solution and Medical Loan Technology & #1 Patient Financial Engagement Solution by Black Book Research in 2024
*Best of KLAS for Patient Financing Services by KLAS Research in 2023
*#1 Patient Financing Solution and Medical Loan Technology by Black Book Research in 2022
Experience · 4 entries
All (4)
Investments (2)
Founder (2)
Board (1)
2022
Co-Moderator of the ACA Impact Investing Angel Syndication Group
Oct 2022
The Angel Capital Association (ACA) is the professional society of angel groups and private investors that invest in high growth, early-stage ventures. Our mission is to fuel the success of angel groups and private investors that invest in high growth, early-stage ventures.
ACA provides professional development and delivers services and benefits to support the success of ACA members. We also serve as the promotional voice for the global angel community and the public policy voice for the US professional angel community.
ACA membership includes more than 250 angel groups, accredited platforms and family offices from across the world. Our members represent more than 8,000 accredited investors funding approximately 5,000 portfolio companies.
2020
Co-Founder and General Partner Manager
Sep 2020
VectorPoint is a seed through early growth stage venture firm focused first on investor financial return and second on purpose-driven social and/or environmental impact. Our team has launched VectorPoint Impact Partners L.P. (VIP) to fund and accelerate emerging companies that are addressing some of society’s most pressing challenges. VIPs managers have over sixty years combined experience investing in and advising early and growth stage companies from pre-investment through exit.
VIP’s objective is to provide superior investment returns to investors while also doing good by catalyzing and accelerating successful businesses, creating lasting positive social and/or environmental impact in the world. VIP’s primary focus areas are life sciences & health and clean technology companies that are based in the United States and Canada. One of our goals is also to invest in portfolio companies that are lead or founded by teams that include women or other minorities with 50% or more of VIP’s available capital. By advising and mentoring company teams, we bring additional value to companies we work with, helping accelerate growth and potential return for investors.
2011
Co-Founder and Managing Director
May 2011
VectorPoint is a seed through early growth stage venture firm focused first on investor financial return and second on purpose-driven social and/or environmental impact. Motivated to make a positive difference in the world with our work, VectorPoint’s team accelerates emerging companies that are addressing some of society’s most pressing challenges. This is also why, in addition to our work at VectorPoint Ventures, we formed VectorPoint Impact Partners L.P. (VIP) to fund and accelerate emerging companies that are addressing some of society’s most pressing challenges. VIP is managed by Jolene Anderson, Don Megrath and Rick Nagle, with over sixty years combined experience investing in and advising early and growth stage companies from pre-investment through exit.
VIP’s objective is to provide superior investment returns to investors while also doing good by catalyzing and accelerating successful businesses, creating lasting positive social and/or environmental impact in the world. VIP’s primary focus areas are life sciences & health and clean technology companies that are based in the United States and Canada. One of our goals is also to invest in portfolio companies that are lead or founded by teams that include women or other minorities with 50% or more of VIP’s available capital. By advising and mentoring company teams, we bring additional value to companies we work with, helping accelerate growth and potential return for investors.
2009
Interim Board Member and Audit Committee Member
Dec 2009
Out-of-pocket healthcare expenses are on the rise. Patients are having difficulty paying their share and providers are finding it difficult to collect from those patients. It’s a lose-lose situation.
Enter CarePayment. Our award-winning, always 0.00% APR patient financial engagement helps patients afford the care they need and protect their financial health while helping providers stay financially healthy by reducing bad debt and improving cash flow.
*#1 Patient Financing Solution and Medical Loan Technology & #1 Patient Financial Engagement Solution by Black Book Research in 2024
*Best of KLAS for Patient Financing Services by KLAS Research in 2023
*#1 Patient Financing Solution and Medical Loan Technology by Black Book Research in 2022
